A Phase I Study of Pegylated Arginine Deiminase (Pegargiminase), Cisplatin, and Pemetrexed in Argininosuccinate Synthetase 1-Deficient Recurrent High-grade GliomaPeter E. Hall, Peter W. Szlosarek, Rachel Lewis et al.|Clinical Cancer Research|2019Cited by 70
Analysis of heterogeneity in T2-weighted MR images can differentiate pseudoprogression from progression in glioblastomaThomas C. Booth, Kevin M. Brindle, Timothy J. Larkin et al.|PLoS ONE|2017Cited by 49
Brain tumor research in the United Kingdom: current perspective and future challenges. A strategy document from the NCRI Brain Tumor CSGKathreena M. Kurian, Colin Watts, Paul M. Brennan et al.|Neuro-Oncology Practice|2017Cited by 12
Comment on “The role of imaging in the management of progressive glioblastoma. A systematic review and evidence-based clinical practice guideline” [J Neurooncol 2014; 118:435–460]Thomas C. Booth, Adam Waldman, Sarah Jefferies|Journal of Neuro-Oncology|2014Cited by 6
Neuro-Oncology Single-Photon Emission CT: A Current OverviewThomas C. Booth, John Buscombe, Yenzhi Tang et al.|Neurographics|2011Cited by 6